PET-CT Based Non-Invasive Radiomic Biomarkers as a Part of Precision Medicine Initiative to Predict Local Recurrences in Oral Cancers

Abstract

75-80% of patients who are diagnosed with cancer in India have advanced disease(Stage III and Stage IV) that is not amenable to curative treatment, which means that they are likely to have pain and other symptoms and psychosocial concerns. These burdens vary with the economic and political situations and are affected by such factors as legal restrictions on access to drugs to relieve pain, and a medical culture in which quality-of-life considerations are undervalued in relation to imperatives to treat. These issues could be ameliorated by increased investment in cancer screening, removal of restrictions on prescription of opioids, and improvements in medical education to increase recognition of treatment futility.Oral cancer is the sixth most common cancer worldwide and continues to be most prevalent cancer related to the consumption of tobacco, alcohol and other carcinogenic products. Nevertheless, significant reduction in mortality has been achieved by advances in early diagnosis and implementation of multidisciplinary treatment programs leading to improvement of survivorship and better quality of life [1]. Even with recent advances in cancer diagnosis and therapy, treatment outcomes for many cancers remain dismal. Patients often show different response to the same therapy regimen, supporting the development of precision medicine. There has been increased use of positron emission tomography (PET) using [18F] Fluoro-2-deoxy-d-glucose (FDG),a glucose metabolism analog, for prediction of outcomes and guiding the precision medicine in tumor detection, staging, and treatment planning and surveillance post therapy in head and neck cancer sites [2]. Accumulating evidence of recent literature suggests that pre-treatment FDG uptake could be used as a prognostic factor for predicting treatment outcomes and is motivated by the fact that radiotracer uptake in the tumor is dependent on the characteristics of the microenvironment, quantitative analysis of FDG uptake is based on changes in the standardized uptake value (SUV) [3], However, sole SUV measurements are potentially impacted by the initial FDG uptake kinetics and radiotracer distribution and there is significant inter and intra observer variability in interpreting the results [4]. Recent development in Radiomics provides a promising objective way for tumor assessment, which uses computerized tools to extract a large number of image features that capture additional information not currently used in clinic that has prognostic value [5]. Radiomics is a process designed to extract a large number of quantitative features from digital images, place these data in shared databases, and subsequently mine the data for hypothesis generation, testing, or both. Radiomics is designed to develop decision support tools; therefore, it involves combining radiomic data with other patient characteristics, as available, to increase the power of the decision support models [6].

Authors and Affiliations

Lohith G, Suthirth Vaidya, Shivkumar Swamy, Vishal Rao, Sudhakar Sampangi,, Kallur KG, Basavalinga Ajai kumar

Keywords

Related Articles

Mineral Contents of Selected Medicinal and Stimulating Plants in Ethiopia

Mineral elements play a critical role in building body tissues and regulating numerous physiological processes. They are thus essential constituents of enzymes and hormones; regulate a variety of physiological processes,...

Allergic Rhinitis in Children - New Therapeutic Options

Allergic rhinitis (AR) is an inflammatory process of the nasal mucosa, most often IgE dependent, caused by environmental allergens. Typical symptoms of the disease are: an aqueous secretion from the nose, nasal congestio...

Child Genius of Biomolecules: Exosomes and Perspective on Lung Cancer

Exosomes are bioactive receptors which is indirectly originating from the cell membrane. The dimensions vary between 50-140 nm. The most important features distinguishing exosomes from other extracellular vesicles (micro...

Overall Management of Individualized Treatment for a Patient with Advanced NSCLC

Objective: This article analyzes the overall management of a patient with advanced non-small cell lung cancer who has been managed for a total of 4 years and provides a reference for clinical case management. Methods: A...

Adenosine A2A Receptor Stimulation: A New Strategy for the Treatment of Periodontitis

Periodontitis is an unpleasant clinical condition in which an exaggerated inflammatory reaction occurs in the extravascular gingival tissue. Inflammatory cells release cytokines that amplify tissue inflammation and creat...

Download PDF file
  • EP ID EP570595
  • DOI 10.26717/BJSTR.2017.01.000272
  • Views 179
  • Downloads 0

How To Cite

Lohith G, Suthirth Vaidya, Shivkumar Swamy, Vishal Rao, Sudhakar Sampangi, , Kallur KG, Basavalinga Ajai kumar (2017). PET-CT Based Non-Invasive Radiomic Biomarkers as a Part of Precision Medicine Initiative to Predict Local Recurrences in Oral Cancers. Biomedical Journal of Scientific & Technical Research (BJSTR), 1(3), 678-681. https://europub.co.uk/articles/-A-570595